Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

NCT00507793 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

385

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Sirolimus
DRUG: Cyclosporine

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer